Spotlight
Obituaries
Classifieds
Families First
VCAs Best of Guide
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Recommended
Pumpkin patches, fall and Halloween events in NC
Recommended
Climate change is reshaping North Carolina's fall colors
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about TC Biopharm
Recent news which mentions TC Biopharm
3 Patients Already Dosed In TC BioPharm's Phase 2b Trial Of A Cutting Edge T Cell Therapy For Hard-to-Treat Cancers
January 26, 2023
Tickers
TCBP
Tags
TCBP
Market News
Penny Stocks
From
Benzinga
TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid Leukemia
November 22, 2022
Tickers
TCBP
TCBPW
Tags
Benzinga
General
TC Biopharm
From
Benzinga
Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved
November 22, 2022
Tickers
ACET
BMY
IPSC
TAK
Tags
TC Biopharm
Benzinga
Biotech
From
Benzinga
TC BioPharm Says It Aims To Deliver A Big Breakthrough In Cancer Treatments
August 08, 2022
Tickers
BMY
TCBP
TECH
Tags
Partner Content
Rumors
General
From
Benzinga
TC BioPharm Reports Racing Toward What Could Be A Major Cancer Immunotherapy Breakthrough
June 02, 2022
Tickers
BLUE
TCBP
Tags
BLUE
TCBP
Market News
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.